NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
Back to search
Official data from USPTO
SUPRAANTIGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SUPRAANTIGEN
ST13
US500000088636138Class
1, 5, 42
Filing
88636138
Registration
6909261
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/29/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
09/30/2019
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Lausanne, CH
Examiner
KUMIS, SCOTT N
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AC Immune SA
Representatives
Kristina Montanaro Schrader Adams and Reese LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemical substanceschemical materials and chemical preparationsnatural elementschemical preparations for industrial and scientific purposesother than for medical or veterinary use; chemicalbiochemicalbiological and biotechnological preparations for use in industry and science; proteinprotein fragmentsamino acidsantibodies and fragments thereof for industrialscientific or research purposesother than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular librariescomprising libraries of chemical preparations for use in industry and science; small molecule librarycomprising libraries of chemical preparations for use in industry and science; antibody librarycomprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodiesproteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrialscientific purposes; diagnostic reagents for industrialscientific or research purposes; immunological reagents for industrialscientific or research purposes; biological cellbiological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparationscompanion diagnostic agentsbiomarkersimaging agentsPET-Imaging compounds for industrialscientific purposes other than for medical or veterinary use; diagnostic reagents for industrialscientific or research purposes other than for medical or veterinary use
Class 5
Pharmaceuticalsmedical and veterinary preparations for the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agentsbiomarkersimaging agentsPET-Imaging compoundsall for medical purposes; chemical preparations for medical purposesfor the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposesfor the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodiesantibody fragments and antibody derivatives for use in disease testingdiagnosisprevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosisprevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
Class 42
Scientific and technological servicesscientific researchanalysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodiesvaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnologychemistrypharmacymolecular science and immunotherapy; providing medical and scientific research information in the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; scientific researchdevelopment and consultancy in the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; development of test proceduresassaystest reagentsPET-imagingcompanion diagnostic biomarkersantibodiesvaccines and test kits for the field of biotechnologychemistrypharmacymolecular scienceimmunotherapytherapeuticsdiagnostics and clinical trials; biological researchscreening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and developmentvaccine and antibody engineering
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/26/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/26/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/10/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2022
EX1G
SOU EXTENSION 1 GRANTED
05/09/2022
EXT1
SOU EXTENSION 1 FILED
05/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/27/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/08/2021
ALIE
ASSIGNED TO LIE
07/06/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/13/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/05/2020
GNSL
LETTER OF SUSPENSION E-MAILED
08/05/2020
CNSL
SUSPENSION LETTER WRITTEN
08/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2020
ALIE
ASSIGNED TO LIE
07/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2020
GNRT
NON-FINAL ACTION E-MAILED
01/07/2020
CNRT
NON-FINAL ACTION WRITTEN
01/07/2020
DOCK
ASSIGNED TO EXAMINER
01/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2019
NWAP
NEW APPLICATION ENTERED
10/03/2019
Continuous trademark protection
Get notified about every new filing that threatens SUPRAANTIGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.